Proposition 14, the California Stem Cell Research, Treatments and Cures Initiative of 2020, will provide a boost to the institute through a general obligation bond fund, according to the release.
Californians for Cures, the organization behind the campaign to approve the proposition, said the funding will drive research and development of treatments for illnesses and conditions including neurodegenerative diseases, strokes and more, according to a Nov. 12 press release.
“We are already working on ways to repay that trust and bring stem cell and regenerative therapies to all the people of this great state, particularly for communities that have traditionally been overlooked or underserved,” Jonathan Thomas, PhD, CIRM board chair, said in the statement.
Read the CIRM press release here and information from Californians for Cures here.
More articles on biologics:
The most controversial trends in spine from 10 surgeons
Dr. Ali Baaj to build UArizona-Banner spine program from scratch in new role
Investment firm bets big on spine device company that rejected Stryker takeover
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
